# Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children

> **NCT01900899** · PHASE3 · COMPLETED · sponsor: **Pfizer** · enrollment: 184 (actual)

## Conditions studied

- Infections, Meningococcal

## Interventions

- **PROCEDURE:** Blood Sampling

## Key facts

- **NCT ID:** NCT01900899
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2017-11
- **Final completion:** 2017-11
- **Target enrollment:** 184 (ACTUAL)
- **Last updated:** 2019-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01900899

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01900899, "Persistence of Antibodies After Meningococcal Vaccine PF-06866681 in Healthy Children". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01900899. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*